OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
February 02, 2023
This new pioneering phase of mRNA is loaded with potential, but also obstacles and false dawns.
January 16, 2023
Materials enhance sustainability and efficiency.
January 03, 2023
Bio/pharma has evolved and adapted to a variety of challenges in 2022, but what might be on the cards for the industry in 2023?
January 02, 2023
Manufacturers must consider key components of manufacturing solid versus semi-solid drugs to create a successful end product.
TreeFrog Therapeutics is leaping ahead in cell therapies through resources such as new technologies and investor partnerships.
The latest report from Clarivate has been published, highlighting 15 potential blockbusters to watch out for in 2023, the majority of which are personalized medicines.
December 07, 2022
One can improve method precision and productivity by replacing one step in sample preparation with an automated approach.
December 03, 2022
Unique solutions are required to protect inherently unstable messenger RNA.
Unique dosage forms, personalized medicine, and flexible manufacturing are possible with 3DP.
November 28, 2022
SPX-001, a respiratory drug candidate, will be submitted through a combined Clinical Trial and Ethics Committee application for further advancement in the clinical stages.